Featured publications

  • Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity

    Authors:
    Hanna BS*; Llaó-Cid L*; Iskar M; Roessner PM; Klett L;
    (...)
    Feuerer M; Ramsay AG; Lichter P; Zapatka M; Seiffert M. .
    Reference: 2021.
  • EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia

    Authors:
    Llaó-Cid L; Roessner PM; Chapaprieta V; Öztürk S; Roider T;
    (...)
    Dietrich S; Stilgenbauer S; Hanna BS; Martín-Subero J; Seiffert M.
    Reference: 2021.
  • EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia

    Authors:
    Roessner PM*; Llaó Cid L*; Lupar E*; Roider T; Bordas M;
    (...)
    Stilgenbauer S; Dietrich S; Lichter P; Izcue A; Seiffert M. .
    Reference: 2021.
  • Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?

    Authors:
    Roessner PM; Llaó Cid L; Lupar E; Roider T; Bordas M;
    (...)
    Stilgenbauer S; Dietrich S; Lichter P; Izcue A; Seiffert M.
    Reference: 2021.
  • TBET-expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in E?-TCL1 mice

    Authors:
    Roessner PM; Hanna BS; Öztürk S; Schulz R; Llaó Cid L;
    (...)
    Scheffold A; Colomer D; Stilgenbauer S; Lichter P; Seiffert M.
    Reference: 2019.
  • CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion

    Authors:
    Llaó-Cid L; Hanna BS; Iskar M; Roessner PM; Öztürk S;
    Lichter P; Zapatka M; Seiffert M.
    Reference: 2019.
  • Tumor-derived exosomes modulate PD-L1 expression in monocytes

    Authors:
    Haderk F; Schulz R; Iskar M; Llaó Cid L; Worst T;
    (...)
    Moussay E; Stilgenbauer S; Zapatka M; Lichter P; Seiffert M.
    Reference: 2017.